Osimertinib in First-Line Treatment—is a Comparison Not Proof?

Annals of Translational Medicine - China
doi 10.21037/atm.2017.12.13
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

AME Publishing Company